Our Insightful & Visionary Advisory Board

An Event Shaped by a Community of Your Peers!
Frost & Sullivan extends its appreciation to the following Advisory Board Members for their expertise and valuable support in ensuring the agenda delivers relevant and valuable content.

Advisory Board

Greg Caressi

Greg Caressi

Senior Vice President, Frost & Sullivan

Greg Caressi is the Americas business unit leader for the Transformational Health practice at Frost & Sullivan, leading the Life Sciences, Advanced Medical Technology and Connected Health teams.

Full Bio
In addition to his leadership responsibilities, Greg spends most of his time working on strategic consulting projects on next-generation healthcare solutions, with a primary focus on connected health and integrated health solutions. Greg served for two years as the Chair of the HIMSS Life Sciences Information Technology Committee, where he led the creation of industry guidance for Good Informatics Practices used by life science companies, from startups to major pharmaceutical companies.   Greg regularly serves as chair, speaker and leader of interactive workshops at major industry events in the U.S., Asia, and Latin America.
W. Andrew Cousin, Jr., MBA, FACHE

W. Andrew Cousin, Jr., MBA, FACHE

Senior Director of Strategy at Mayo Medical Laboratories, Mayo Clinic

W. Andrew Cousin, MBA, FACHE is the Senior Director of Strategy for Mayo Clinic Laboratories, the diagnostic outreach arm of Mayo Clinic, which touched more than 5 million patients in 80 countries last year.

Full Bio
He is also a member of the leadership team of Mayo Clinic’s Department of Laboratory Medicine and Pathology. In Andrew’s 12 years at Mayo Clinic, he has contributed to thinking on value-based care delivery, outreach strategy, the application of advanced diagnostics in complex condition management, disruptive digital technologies in medicine, utilization management, and alternative payment models. He holds a Bachelor of Arts in Communication and Public Relations from the University of Delaware, a Master of Business Administration with distinction from the New York Institute of Technology, and has participated in select scientific and medical classes through the Mayo Clinic Graduate School. Andrew also holds Fellowship in the American College of Healthcare Executives. He has authored more than 20 articles on product management and marketing in healthcare; and he has spoken at several national conferences on emerging healthcare and marketing topics. He resides in Rochester, MN with his wife Dr. Margot Cousin, and his two sons Owen and Brooks.
Reenita Das

Reenita Das

Partner & Senior Vice President Global, Healthcare & Life Sciences Frost & Sullivan

25 years of healthcare consulting expertise, which include engaging with global clients and start ups to develop and implement growth strategies. Particular expertise in:

Full Bio

25 years of healthcare consulting expertise, which include engaging with global clients and start ups to develop and implement growth strategies. Particular expertise in:

  • Futuristic forecasts and understanding the place of healthcare 20 years from today- working with clients on the impact of these mega trend changes to their business
  • Changing business models and convergence issues: identifying opportunities with companies outside of healthcare to bring  solutions to the healthcare sector. Experience in working with companies for reverse innovation development
  • Best Practice mapping of core capabilities
  • Understanding of emerging markets and the challenges of the complex business scenario enabling unique strategies to penetrate and operate efficiently. 10 years on the ground experience in Malaysia, Singapore, Korea, Brazil and Russia
  • Current contributor to Forbes http://www.forbes.com/sites/reenitadas/

Industry Expertise

  • Experience base covering broad range of sectors and industries, leveraging long-standing working relationships with leading industry participants in

Medical devices and medical technology, connected health applications

Pharmaceuticals and diagnostics

Related industries such as CMOs and CROs, Regulatory. Logistics, information and communication technology,

What I bring to the Team

  • Broad range of skills sets from unique problem definition, implementation and managing a global P & L business
  • Extensive experience in sales and business development including negotiation, strategy planning , conflict resolution, etc.
  • Ability to go into a new market and build a practice from scratch: examples include Malaysia, Singapore, Korea, Brazil, Russia. Currently investigating the next generation of countries such as Mexico, Turkey, Indonesia

Career Highlights

Extensive expertise in product launches, due deligence work,  competitive intelligence, pricing models, distribution analysis, branding,. Extensively quoted in the press and TV such as Wall Street Journal, San Jose Mercury News, CNN,CNBC, BBC, Fierce Healthcare,

Current contributor covering healthcare and disruptive technologies for Forbes

Rahul Dubey

Rahul Dubey

Former Senior Vice President, Innovation and Solutions, American Health Insurance Plans (AHIP)

Rahul is currently responsible for collaborating with the C-level executives at AHIP’s Health Plan Membership to develop and implement innovative, best in class, emerging solutions and approaches that accelerate utilization of these mission critical applications in order to deliver a higher quality of care, improving the wellbeing of consumers and driving down the cost of care received.

Full Bio
Rahul has extensive practical knowledge in regard to creating new, multi-stakeholder, collaborative business models as well as optimizing the use of effective next gen digital health solutions that create a simplified and positive consumer care experience. His role expands to include efforts on initiatives that have led to the creation of innovative care pathways, normalizing and sharing of data to build new and viable care measures, developing actionable and personalized programs and tools that ensure behavior change resulting in increased desired health outcomes. He continues to help develop, test, measure and iterate innovative platforms that increase efficiencies for all key stakeholders as they collectively focus on outcomes driven care.
Rahul’s most recent brainchild is the 26,000 sq ft AHIP Innovation Lab in Chicago’s West Loop. He is responsible for creating the Lab’s one of a kind concept, continues to fulfill its mission of delivering an invaluable resource for AHIP Membership and leads all of the Lab’s collaborative and confidential Solution Working Groups that involve individual payers, providers, manufacturers, MedTech, innovative solution providers and the AHIP Innovation Lab’s trusted and crucial Inaugural Partners.
Prior to joining AHIP, Rahul played a leadership role as a founding employee of a successful Digital Healthcare start-up based in Washington DC, WiserTogether. Along with WiserTogether’s Co-founders, Rahul was instrumental in developing their payer, provider and consumer focused platform as well as the company’s “go to market” strategy which resulted in successful market penetration for the industry’s first ever consumer-led shared decision making and treatment selection platform.
Rahul invites you to learn more about the AHIP Innovation Lab through their video overview located here: Welcome to the AHIP Innovation Lab
Daniel Durand

Daniel Durand

Vice President and Chairman, LifeBridge Health

Dr. Daniel J Durand, M.D. (“Dan”) is a physician executive with deep expertise in value-based care. He has served multinational corporations, ACOs, healthcare startups, provider-owned health plans, government agencies, and top-ranked academic institutions.

Full Bio
Dan began his medical career on the radiology faculty at The Johns Hopkins Hospital before working as an Associate with McKinsey & Company advising hospitals and health systems on post-ACA Strategy and Operations. He then joined the Executive Leadership Team at Evolent Health, where he served as the first Vice President of Clinical Transformation and helped grow revenues from $8M to over $118M en route to a successful IPO on the New York Stock Exchange.

Dan then served as the first Director of Accountable Care for Johns Hopkins before taking his current role as Chair of Radiology and Vice President of Clinical Strategy for LifeBridge Health System, where he has led the LifeBridge Health Clinically Integrated Network to become one of the most successful ACOs in the country.

Dan’s writing has appeared in top journals such as The New England Journal of Medicine (NEJM) and the Journal of the American Medical Association (JAMA). He regularly lectures at national conferences on topics related to medical innovation and is the president of Durand Ventures, a healthcare consulting practice that also takes equity positions in select digital health start-ups.

Kolaleh Eskandanian

Kolaleh Eskandanian

Vice President and Chief Innovation Officer, Children's National Health System

Kolaleh Eskandanian is the VP and Chief Innovation Officer Children’s National Medical Center. In this role she oversees the Office of Innovation and Technology Commercialization, the Sheikh Zayed Institute’s operations, and plays a leadership role in the development of the Children’s National Research and Innovation Campus at Walter Reed (2020). She is the Principal Investigator of the FDA-funded National Capital Consortium for Pediatric Device Innovation (NCC-PDI), focused on accelerating the path to market for pediatric devices.

Full Bio

Kolaleh works with a large network of small and large businesses, nonprofits and government agencies—addressing the unmet medical needs of children. Kolaleh’s expertise includes the full spectrum of product development activities, having held management positions at Accenture, a global management consulting firm, where she directed major product launches for clients. Dr. Eskandanian is also the co-PI on the FDA-funded Global Pediatric Clinical Trials Network grant and the CTSI-CN lead of the Orphan Product Accelerator. Dr. Eskandanian’s own innovations are in the market space, used by millions. She is the lead inventor of the first-ever adverse event reporting system, initially deployed in a research academic environment. Prior to joining Children’s National, Dr. Eskandanian held positions with Intelsat, Accenture, and Georgetown University. Her background is in mechanical engineering with a PhD in operations science and an MBA from American University Kogod School of Business.

Donald R. Flott

Donald R. Flott

Senior Director of Utilization Management Mayo Medical Laboratories, Mayo Clinic

Bio is forthcoming.

Robert GoFourth

Robert GoFourth

Vice President, Operations Strategy & Performance, BlueCross BlueShield of North Carolina

Robert has more than 20 years of operations and risk management experience across a variety of industries including insurance, mortgage banking, government enterprise, and outsourcing.

Full Bio

In 2014, Robert accepted the position of Vice President of Operational Strategy and Performance at BlueCross BlueShield of North Carolina, Robert is responsible for the overall Quality, Compliance, Analytics, Process and Informatics programs.

Robert has been a certified Six Sigma Master Black Belt since 1999. After earning his M.B.A., he applied a combination of process improvement and operational knowledge to drive quality, reduce cost and improve efficiency to the benefit of several companies. Prior to joining BCBSNC, he was with Citizens Property Insurance Corporation, a government entity acting as the insurer of last resort for the State of Florida. Robert first held the position of Vice President of Operations, improving performance levels which could compete with private enterprise. His final position at Citizens was Vice President of Enterprise Risk Management. As the corporate officer in charge of risk, he utilized his knowledge of process improvement and operations to develop and deploy the company’s risk program which ultimately helped the company in achieving its mission and strategic goals.

Matthew Jenusaitis

Matthew Jenusaitis

Chief of Staff/ Director of Innovation, University of California – San Diego Health System

Matthew Jenusaitis is Chief of Staff and Chief of Innovation and Transformation at the University of California San Diego Health System.

Full Bio

Matthew oversees business development, new technology acquisition and implantation, regional hospital affiliations, and organizational efficiency improvements at the six UC San Diego Hospitals and four regional affiliates.

Prior to UC San Diego, Matthew was the President and CEO of OCTANe, an Orange County, CA non-profit organization focused on connecting people and ideas with capital and resources to fuel high technology innovation and economic development. OCTANe assisted more than 200 companies raise more than $500 Million in early stage capital building the high technology ecosystem in Southern California.

Matthew is an experienced health care professional with more than 25 years of engineering, sales and marketing, and executive level general management experience.

Matthew spent 15 years at Boston Scientific Corp., where he served in numerous presidential, general management, and executive marketing positions. His most recent position with Boston Scientific was as the president of the $600 Million Peripheral Interventions Division (formerly Medi-Tech) leading the acquisition and integration of Cryovascular Systems, Inc. and EndoTex, Inc..
Prior to Peripheral Interventions, Matthew led the integration of Interventional Technologies increasing their annual revenues from $25 Million in 2001 to more than $150 Million in 2003. Before that, he held executive marketing and marketing management positions in the Microvasive Endoscopy, Boston Scientific International, and Scimed Life Sciences divisions.

Matthew was also an executive in residence for the private equity firm Warburg Pincus, LLC. This led to Matthew assuming the role of President of ev3 Neurovasuclar, one of Warburg’s portfolio companies. During his career, Matthew also spent 8 years at Baxter Healthcare in both marketing and engineering management positions.

Matthew served on the board of directors of Creagh Medical in Galway, Ireland, a developer and manufacturer of specialty angioplasty balloons which sold to Surmodics for $32 Million in November 2015, and Pulsar Vascular in Santa Clara, CA, an early stage developer and manufacturer of neurovascular implants for the treatment of hemorrhagic stroke that sold to Johnson and Johnson in December 2016.

He sits on the advisory boards for Cornell’s School of Biomedical Engineering and Chapman University’s Schmid School of Science and Technology. He is also on the non-profit Board of Directors for Junior Achievement in Orange County, OC STEM, a 501c3 focused on the enhancement of STEM education in the school system, and Clean Tech OC, an organization focused on the economic enhancement of clean technology companies and the support of sustainable practices.

Jenusaitis holds a bachelor of science in chemical engineering cum laude from Cornell University, a master of science in bio-chemical engineering from Arizona State University and a master of business administration from University of California, Irvine. Matthew’s wife Lara is an assistant professor at the University of St. Augustine, and an assistant clinical professor of anatomy at the University of California, San Diego in both the medical and pharmacy schools. They live with their two daughters, Jada and Jenna, in Encinitas, California.

Barabara Loeb MD, MBA, CPE, FACP, FACPE

Barabara Loeb MD, MBA, CPE, FACP, FACPE

Chief Medical Officer, Loyola Medicine

Bio is forthcoming.

Maulik Majmudar, M.D.

Maulik Majmudar, M.D.

Associate Director, Healthcare Transformation Lab, Massachusetts General Hospital

Dr. Maulik Majmudar is a practicing cardiologist and Associate Director of the Healthcare Transformation Lab at Massachusetts General Hospital.

Full Bio

Maulik was also a Founding Member and Chief Clinical Officer at Quanttus, Inc., a venture backed startup that is transforming personal health via novel wearable technology that enables continuous physiologic monitoring.

He also advises a number of other start-ups, leveraging his strong clinical training in internal medicine and cardiology. He enjoys teaching and lectures at Massachusetts Institute of Technology in areas of healthcare innovation & entrepreneurship, as well as medical device design and development.

Dr. Majmudar started his career as a medical student at Northwestern University Feinberg School of Medicine, completed resident training in Internal Medicine at The Johns Hopkins Hospital, and followed by a fellowship in Cardiovascular Medicine at Brigham and Women’s Hospital at Harvard Medical School. After finishing his clinical training, he pursued his scholarly interest in advanced cardiovascular molecular imaging as a post-doctoral fellow in the laboratories of Matthias Nahrendorf and Ralph Weissleder at the Center for Systems Biology at MGH. He holds a patent and has had several peer-reviewed publications in high-impact journals, such as Nature and Circulation.

David Mohr

David Mohr

Vice President for Clinical Informatics and Transformation, Sentara Healthcare

Bio is forthcoming.

Sandra Potter LCSW, MBA

Sandra Potter LCSW, MBA

Vice President & Chief Operations Officer of Behavioral Health, Texas Health Resources

Sandy is a Licensed Clinical Social Worker with an MSSW from The university of Texas at Arlington and an MBA from Texas Woman’s University. She is currently the Vice President and COO of behavioral health for Texas Health Resources. With 24 hospitals around Dallas-Fort Worth, Texas Health Resources is a significant provider of behavioral health services with 5 inpatient locations, 16 outpatient clinics and Texas Health Recovery and Wellness Center which is a substance use disorder Residental Treatment Center. Sandy leads her teams in providing services across the system, promoting early intervention, integrated care and is focused on reducing stigma and improving access to care.

Full Bio

Prior to joining Texas Health, Sandy was employed with Health Care Services Corporation / Blue Cross Blue Shield of five state region including Illinois, Texas, Oklahoma, Montana and New Mexico. In her role as Divisional Vice President, she managed physical health services for Medicaid and Medicare members managing teams in Texas and New Mexico. Prior to this role Sandy was the President and CEO, ValueOptions Texas, and in that role was honored with the National Alliance on Mental Illness (NAMI) Dallas’ 2014 Professional of the Year Award. In 2015 Sandy was recognized by the Dallas County commissioners court in for her contributions to Dallas County throughout her career which has spanned over 30 years equality balanced between the provider and payor side.

Rasu Shrestha, MD, MBA

Rasu Shrestha, MD, MBA

Chief Innovation Officer, University of Pittsburgh Medical Center, Executive Vice President, University of Pittsburgh Medical Center Enterprises

Bio is forthcoming.

Marnie Staehly

Marnie Staehly

Director, Market Development & Strategy, Humana Inc.

Marnie joined Humana in 2006 and has over fourteen years of experience in the health care industry. She is currently a Director in Market Development & Strategy at Humana

Full Bio
in which she is leading work to create a best in market value based solution that leads to collaboration with physician partners in an effort to improve population health. She is recognized most recently for her accomplishments as the Strategic Integration Leader for the San Antonio Bold Goal Market building relationships with community partners to support Humana’s Bold Goal initiative and providing strategic input and leadership to the San Antonio Health Advisory Board (SAHAB). In 2017 Marnie celebrated the successful launch of the San Antonio Diabetes Resources Guide, a collaborative project with the SAHAB and American Diabetes Association. During her time with Humana, Marnie has served in strategic and leadership roles in underwriting, commercial sales, and wellness engagement. Marnie received her Bachelor’s Degree in Business Administration from the University of Wisconsin – Green Bay and her MBA from the University of Colorado – Colorado Springs.
Eric Steager

Eric Steager

Director, Corporate Development & Innovation Managing Director, Strategic Innovation Portfolio, Independence Blue Cross

Mr. Steager is a Managing Director, Strategic Innovation Portfolio and Director of Corporate Development & Innovation for Independence Blue Cross, focused on the identification, analysis and execution of strategic equity investments, as well as mergers and acquisitions.

Full Bio

He is also an Adjunct Professor of Finance and Entrepreneurship at Drexel University.

Prior to joining IBC, he spent several years at both a private investment firm focused on venture capital and private equity investments, and Safeguard Scientifics, a publicly traded venture capital firm. Prior to Safeguard, Mr. Steager’s career included founding a private investment fund focused on acquiring middle market manufacturing companies in the Midwestern United States, and healthcare investment banking at Houlihan Lokey and Ernst & Young.

Mr. Steager holds an MBA with honors from the University of Chicago, Booth School of Business and a bachelor’s degree from Drexel University.

Lynn Witherspoon

Lynn Witherspoon

Chief Medical Information Officer Emeritus, Ochsner Health System

Dr. Witherspoon brings extensive expertise in clinical innovation. His pioneering work in Nuclear Medicine and Clinical Immunoassay is documented in numerous publications.

Full Bio

As System VP and Chief Information Officer at Ochsner he architected an electronic health record, creating patient engagement and interoperability solutions where none existed. The recipient of a Most Wired Innovator Award and recognized for innovation by Healthcare Informatics and New Orleans City Business, he is an enthusiastic advocate for clinical innovation in his current role as Chief Medical Information Officer at the Ochsner Health System.

Share This